Qatar Investment Authority’s $470 million joint venture with BRF to acquire 79.5 percent stake in Banvit Bandirma Vitaminli Yem Sanayii A.Ş.

White & Case LLP has advised the Qatar Investment Authority (QIA) on a joint venture between QIA and BRF, the Brazilian food manufacturer, to acquire a 79.5 percent stake in Banvit Bandirma Vitaminli Yem Sanayii A.Ş., a leading Turkey-based poultry company. QIA will hold 40 percent in the joint venture and BRF 60 percent. This […]

PMV and SmartFin Capital’s acquisition of a significant stake in Newtec

PMV and SmartFin Capital acquired a significant stake in Newtec, a world-renowned specialist in satellite communications with offices in eight different countries. Their specialty R&D cleared the path for an impressive array of innovations, partnerships, standardization and industry recognition. Newtec plays a crucial role in the worldwide satellite communications industry. Over two billion people daily […]

Vestiaire Collective: levée de fonds de V €58 millions.

Dechert a conseillé dans le cadre de l’opération Vestiaire Collective, marketplace spécialisée dans la vente de produits de luxe d’occasion entre particuliers, a annoncé mardi 24 janvier 2017 une levée de fonds de 58 millions d’euros auprès du fonds Vitruvian Partners, et d’Eurazeo et Idinvest, déjà présents au capital. Depuis sa création en octobre 2009, […]

Grivalia Hospitality’s acquisition of 60% stake in the Pearl Island resort project in Panama

Watson Farley & Williams advised Grivalia Hospitality on the agreement for the purchase from Dolphin Capital Investors of a 60% stake in the Pearl Island resort project in Panama. Grivalia Hospitality is the Luxembourg-based tourism and hospitality subsidiary of Grivalia Properties REIC and this transaction constitutes its first investment. The agreed price for the stake […]

GE Healthcare’s acquisition of Rapidscan Pharma Solutions, Inc.

GE Healthcare’s Life Sciences business announced that it has acquired Rapidscan Pharma Solutions Inc., which has the exclusive rights to produce and sell the pharmacological stress agent Rapiscan® (regadenoson) in territories outside the USA, Canada and Mexico. GE Healthcare’s strong industry presence and existing customer and supply chain network will help bring improved access to […]